Name : Syed A. A. Rizvi

Speciality : Clinical Trials, Medical Affairs, Pharmacovigilance and Drug Safety, Medical and Regulatory writing, Electronic Common Technical Document (eCTD) preparation and submission, Clinical and Translational Research, Direct Patient Care, Telehealth, Drug Discovery and Development, Nanotechnology, Biotechnology, Formulation Development, Targeted and Controlled Release Drug Delivery, Bioavailability Enhancement, Vaccine Development, Crystal Engineering to forming Drug Cocrystals, Medicinal Ionic Liquids, Trace level and Forensic Drug Analysis, High and Ultrahigh Performance Liquid Chromatography (HPLC & UPLC), Natural Product Chemistry, Chiral Separations, Surfactant and Colloidal Chemistry, Chemistry of Fragrance, Multistep Organic Synthesis, Allergy Testing and Immunotherapy, Digital Tool Development for Allergy Assessment, Executive Leadership, Team Building, Marketing and Management, Educational Assessment and Accreditation, Medical Education.

Email : srizvi@larkinhospital.com

Affilation : Professor of Pharmaceutical & Biomedical Sciences and a broadly trained scientist, educator, and healthcare contributor with vast Clinical and Translational Research experience, driving innovation within pharmaceutical product development platforms, Miami, USA.

Dr. Rizvi is a professor of Pharmaceutical & Biomedical Sciences and a broadly trained scientist, educator, and healthcare contributor with vast Clinical and Translational Research experience, driving innovation within pharmaceutical product development platforms. Highly motivated and committed to advancing medical innovation and education, discovering new therapies, improving patient outcomes, and playing an instrumental role in scientific and business strategies. Equipped with extensive training with over 27 years of experience in industrial, academic, administration, and healthcare settings.

Dr. Rizvi has published over 250 peer-reviewed articles (cited over thousands of times), spanning journal publications, book chapters, books, US patents, and oral/poster presentations. His publications include highly rated cover articles, a testament to the quality and impact of his work. He also serves on the Editorial Boards/Panels of different journals (in various capacities) and reviews manuscripts and books for over 300 well-known scientific publications (journals and books).

His research interests incorporate clinical and translational research including clinical trials, medical and regulatory writing; graduate medical education; pharmaceutical formulations (direct compressed tablets, topicals and liquids); ionic liquid formation and cocrystallization of the pharmaceutical compounds; nano and micro-encapsulation of the drugs for targeting and controlled release; nanotechnology; biotechnology; task specific formulation development; multistep synthesis of small organic molecules; bioavailability enhancement; pharmaceutical analysis (forensics and method development); design and synthesis of novel monomeric and polymeric surfactants for separation of chiral and achiral compounds in micellar electrokinetic chromatography (MEKC); method development and validation for separations of achiral and chiral compounds utilizing, HPLC, LC/MS and LC/MS-MS; application of cryogenic high resolution scanning electron microscopy and analytical ultracentrifuge for characterization of polymeric surfactants; amphiphilic polymers; surfactant and colloidal chemistry; chemical transformation of pharmacologically active compounds using microbial whole cultures; isolation and pharmacology of compounds from fungal metabolites and medicinal plants; fragrance and aroma chemistry; skin allergy testing and immunotherapy; digital Tool development for healthcare assessment; executive leadership; team building; marketing and management; and peer-reviewed high impact publications.